A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled Drug

Clinical trial NCT01124747 · COMPLETED

Trial details

NCT number: NCT01124747
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Pharmacokinetics of ASP1585

Start date: 2010-04-01
Primary completion: 2010-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.